KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Long-Term Investments: 2017-2022

Historic Long-Term Investments for Guardant Health (GH) over the last 4 years, with Sep 2022 value amounting to $156.7 million.

  • Guardant Health's Long-Term Investments fell 37.36% to $156.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $156.7 million, marking a year-over-year decrease of 37.36%. This contributed to the annual value of $698.0 million for FY2021, which is 183.07% up from last year.
  • Per Guardant Health's latest filing, its Long-Term Investments stood at $156.7 million for Q3 2022, which was down 59.03% from $382.6 million recorded in Q2 2022.
  • In the past 5 years, Guardant Health's Long-Term Investments registered a high of $698.0 million during Q4 2021, and its lowest value of $3.0 million during Q3 2018.
  • In the last 3 years, Guardant Health's Long-Term Investments had a median value of $242.4 million in 2020 and averaged $281.4 million.
  • As far as peak fluctuations go, Guardant Health's Long-Term Investments soared by 10,113.43% in 2019, and later slumped by 83.02% in 2020.
  • Over the past 5 years, Guardant Health's Long-Term Investments (Quarterly) stood at $77.6 million in 2018, then spiked by 246.54% to $268.8 million in 2019, then declined by 8.25% to $246.6 million in 2020, then spiked by 183.07% to $698.0 million in 2021, then crashed by 37.36% to $156.7 million in 2022.
  • Its last three reported values are $156.7 million in Q3 2022, $382.6 million for Q2 2022, and $588.5 million during Q1 2022.